4//SEC Filing
ACHILLION PHARMACEUTICALS INC 4
Accession 0001181431-15-001443
CIK 0001070336operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:15 PM ET
Size
8.2 KB
Accession
0001181431-15-001443
Insider Transaction Report
Form 4
Fenton Mary Kay
Vice President and CFO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-01-23−13,125→ 0 totalExercise: $4.00Exp: 2015-12-20→ Common Stock (13,125 underlying) - Exercise/Conversion
Common Stock
2015-01-23$4.00/sh+13,125$52,500→ 13,125 total - Sale
Common Stock
2015-01-23$16.00/sh−13,125$210,000→ 0 total
Footnotes (1)
- [F1]This option was granted on December 20, 2005 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070336
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:15 PM ET
- Size
- 8.2 KB